treating advanced/metastatic urothelial carcinoma: recent developments in the bgj398 clinical trial
Published 7 years ago • 131 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:23
recent advances in the use of targeted therapies for metastatic urothelial carcinoma
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
1:17
recent treatment approvals for metastatic and advanced urothelial carcinoma
-
1:09
futibatinib plus pembrolizumab for the treatment of advanced or metastatic urothelial carcinoma
-
20:21
targeted therapy for the treatment of advanced metastatic urothelial cancer youtube
-
2:54
mocetinostat for treated, locally advanced/metastatic urothelial carcinoma
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
4:31
current obstacles in the treatment of urothelial carcinoma
-
1:54
innovations in treatment options for patients with bcg-unresponsive urothelial carcinoma
-
1:34
phase 2 trial of cv301 vaccine plus atezolizumab in advanced urothelial carcinoma
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
2:02
the evolving treatment landscape for urothelial cancer
-
19:59
advances in treating upper tract urothelial cancer
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
2:52
fgfri treatment-emergent aes in urothelial cancer
-
2:17
optimizing treatment options for patients with muscle-invasive urothelial carcinoma
-
3:46
perioperative management of advanced bladder cancer
-
7:53
growing treatment landscape for advanced bladder cancer
-
2:06
main-cav: maintenance cabozantinib and avelumab in urothelial cancer